Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2394422)

Published in Br J Cancer on November 03, 2003

Authors

P Radny1, U M Caroli, J Bauer, T Paul, C Schlegel, T K Eigentler, B Weide, M Schwarz, C Garbe

Author Affiliations

1: Department of Dermatology, Eberhard-Karls-University, Liebermeistersrasse 20, Tübingen 72076, Germany.

Associated clinical trials:

Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases | NCT00204581

Articles citing this

Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res (2008) 1.51

Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J Clin Invest (2005) 1.24

Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol (2014) 1.05

Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials (2011) 1.02

Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res (2010) 1.01

Local therapy of cancer with free IL-2. Cancer Immunol Immunother (2008) 0.93

Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist (2010) 0.89

Targeting the tumor microenvironment to enhance antitumor immune responses. Oncotarget (2015) 0.89

Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. Invest New Drugs (2011) 0.81

A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma. Oncotarget (2016) 0.78

TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial. PLoS One (2014) 0.78

Developments in Intralesional Therapy for Metastatic Melanoma. Cancer Control (2016) 0.77

Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice. Exp Ther Med (2011) 0.77

Local immunostimulation leading to rejection of accepted male skin grafts by female mice as a model for cancer immunotherapy. Proc Natl Acad Sci U S A (2014) 0.76

Melanoma immunotherapy. Cancer Biol Ther (2014) 0.76

Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology. Crit Rev Oncog (2016) 0.75

The effect of interleukin-2 on canine peripheral nerve sheath tumours after marginal surgical excision: a double-blind randomized study. BMC Vet Res (2013) 0.75

Articles cited by this

Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma. J Clin Oncol (2001) 3.05

Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer (1998) 1.54

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin Cancer Res (2000) 1.53

Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46

Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease. J Am Acad Dermatol (2000) 1.43

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. J Clin Oncol (1998) 1.32

Intralesional interferon-alpha therapy in advanced malignant melanoma. Cancer (1988) 1.03

Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol (1996) 0.99

Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma. J Dermatol (1998) 0.92

Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg (1998) 0.87

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res (1993) 0.86

Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. Arch Dermatol (1992) 0.86

Regressive effect of intralesional injection of a moderate dose of recombinant interleukin-2 on carcinoma erysipeloides from gastric carcinoma. Clin Exp Dermatol (2001) 0.86

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice. Int J Cancer (1999) 0.82

Melanoma. A multidisciplinary approach for the general surgeon. Surg Clin North Am (2000) 0.82

Advances in specific immunotherapy of malignant melanoma. J Am Acad Dermatol (2000) 0.81

A case of malignant haemangioendothelioma showing response to interleukin 2 therapy. Br J Dermatol (1992) 0.81

Interleukin 2 gene therapy of surgical minimal residual tumour disease: characterization of cytolytic effector cells from tumour progressors and regressors. Folia Biol (Praha) (1999) 0.80

Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma. Dermatol Surg (2000) 0.80

[Peritumoral administered IL-2-induced tumor regression in melanoma. Pilot study]. Hautarzt (1994) 0.79

Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma. Br J Dermatol (1994) 0.79

A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy. Cancer (2000) 0.79

[Intralesional therapy of melanoma metastases with recombinant interferon-beta]. Hautarzt (1992) 0.79

Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor. Arch Dermatol (1999) 0.79

Therapeutic advances in melanoma. Dermatol Clin (2000) 0.78

Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study. J Immunother (1997) 0.78

Local treatment of cutaneous and subcutaneous metastatic malignant melanoma with fotemustine. Cancer Chemother Pharmacol (1991) 0.77

Intralesional interferon treatment of lentigo maligna. Arch Dermatol (2000) 0.77

Articles by these authors

Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56

A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry (2007) 6.72

Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05

Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98

Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med (1998) 5.79

The molecular basis of lung morphogenesis. Mech Dev (2000) 4.87

Differential abscisic acid regulation of guard cell slow anion channels in Arabidopsis wild-type and abi1 and abi2 mutants. Plant Cell (1997) 3.62

Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol (1995) 3.34

The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chem Biol (1998) 3.23

Management of severe traumatic brain injury by decompressive craniectomy. Neurosurgery (2000) 3.20

Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet (1992) 2.70

Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis (1999) 2.66

Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet (1997) 2.62

Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56

Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46

hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel beta subunit family. FEBS Lett (2000) 2.40

Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29

Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol (2001) 2.24

Human melanoma progression in skin reconstructs : biological significance of bFGF. Am J Pathol (2000) 2.23

Positional cloning of heart and soul reveals multiple roles for PKC lambda in zebrafish organogenesis. Curr Biol (2001) 2.16

Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci (1993) 2.08

Cystic fibrosis, Young's syndrome, and normal sweat chloride. Lancet (1998) 2.06

Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett (1987) 2.04

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique. Ann Hematol (2003) 2.01

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer (2009) 1.93

Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry (2008) 1.92

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia (2001) 1.91

Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nat Med (1995) 1.87

Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem (1996) 1.87

Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation (1993) 1.86

B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85

The isolation of porcine ribonuclease, a glycoprotein, from pancreatic juice. J Biol Chem (1968) 1.83

IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80

Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. Br J Dermatol (1999) 1.79

Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib. Leukemia (2013) 1.77

Effects of cytokines on the liver. Hepatology (1991) 1.76

Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol (2002) 1.71

Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res (2001) 1.69

Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma. J Clin Epidemiol (1997) 1.69

Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest (1998) 1.68

Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66

On the association between valproate and polycystic ovary syndrome. Epilepsia (2001) 1.65

Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol (1996) 1.65

Cleavage of zearalenone-glycoside, a "masked" mycotoxin, during digestion in swine. Zentralbl Veterinarmed B (1990) 1.64

Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma. Ann Oncol (2014) 1.63

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut (2003) 1.62

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol (1998) 1.62

Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61

Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examinations. Cancer (1997) 1.59

Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res (1984) 1.59

Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58

Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol (1992) 1.56

Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br J Dermatol (2001) 1.56

A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype. J Mol Med (Berl) (2001) 1.56

Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54

Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol (1998) 1.54

The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52

Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol (2007) 1.49

Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol (2001) 1.49

A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J (2000) 1.48

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Multidimensional assessment of personality in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry (2004) 1.48

Instantaneous pressure-flow velocity relations of systemic venous return in patients with univentricular circulation. Heart (1999) 1.48

Generic database design for patient management information. Proc AMIA Annu Fall Symp (1997) 1.47

Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47

TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47

Late evaluation of pulmonary function after acute exposure to chlorine gas. Am Rev Respir Dis (1969) 1.46

Sotalol associated torsades de pointes tachycardia in a 15-month-old child: successful therapy with magnesium aspartate. Pacing Clin Electrophysiol (1998) 1.46

Retrovirus-induced insertional mutation in Mov13 mice affects collagen I expression in a tissue-specific manner. Cell (1989) 1.46

Diagnostic delay in psychogenic nonepileptic seizures. Neurology (2002) 1.45

Asymmetric repair of bacteriophage T7 heteroduplex DNA. Mol Gen Genet (1981) 1.44

New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol (1997) 1.44

Targeting of an abundant cytosolic form of the protein import receptor at Toc159 to the outer chloroplast membrane. J Cell Biol (2001) 1.44

Evidence for a non-orthostatic origin of orthostatic tremor. J Neurol Neurosurg Psychiatry (1999) 1.43

Genome-wide survey implicates the influence of copy number variants (CNVs) in the development of early-onset bipolar disorder. Mol Psychiatry (2011) 1.43

Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol (2006) 1.43

Hot topic: Bovine milk samples yielding negative or nonspecific results in bacterial culturing--the possible role of PCR-single strand conformation polymorphism in mastitis diagnosis. J Dairy Sci (2012) 1.42

Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol (1990) 1.42

[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]. Nervenarzt (1996) 1.42

Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. J Am Coll Cardiol (1999) 1.41

Effects of intralipid infusion on blood viscosity and other haemorheological parameters in neonates and children. Acta Paediatr (2004) 1.41

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci (1997) 1.41

[Elective lymph node dissection in primary malignant melanoma]. Hautarzt (1996) 1.39

The greater acceptance and utilization of nurse practitioners. Am J Manag Care (2001) 1.39

Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study. Epilepsia (1999) 1.39

Evaluation of different tubing geometries for high-speed counter-current chromatography. J Chromatogr A (2001) 1.39

Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut (2005) 1.39

[Cerebral angiitis or central side effects after lumbar myelography (with intracerebral vascular spasm)]. Nervenarzt (1994) 1.38

[Merkel cell tumor of the skin]. Dtsch Med Wochenschr (1997) 1.38

Images in cardiovascular medicine. Combined pulmonary artery angiography and tracheobronchography in pulmonary artery sling. Circulation (1997) 1.38

Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol (1996) 1.38

[Correlation between chronic hyperplastic laryngitis and infection with human papillomaviruses]. HNO (1993) 1.38

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol (2001) 1.38

Perforated appendicitis within an inguinal hernia: case report and review of the literature. Am J Gastroenterol (1997) 1.37